Efficacy and safety of high-dose chemotherapy with in vivo purged auto-SCT in relapsed follicular lymphoma: long-term follow-up.
Magni M
Bone Marrow Transplant. 2009 Oct 12;45(6):1119-20. doi: 10.1038/bmt.2009.294
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts
Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cells.
Carlo-Stella C
Blood. 93(11):3973-82.
Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
Carlo-Stella C
Bone Marrow Transplant. 20(6):465-71.
Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells.
Carlo-Stella C
Br J Haematol. 93(3):551-7.
Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers.
Bergamaschi G
Br J Haematol. 78(2):167-72.
Effects of desferrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies.
Dezza L
Leukemia. 3(2):104-7.
Establishment of two Epstein-Barr virus negative Burkitt cell lines from a patient with AIDS and B-cell lymphoma.
Ganser A
Blood. 72(4):1255-60.
Effect of recombinant gamma interferon on the proliferative activity of cultured leukemic cells.
Giordano M
Haematologica. 73(3):187-9.
Effects of recombinant human H-subunit and L-subunit ferritins on in vitro growth of human granulocyte-monocyte progenitors.
Dezza L
Br J Haematol. 68(3):367-72.